HarborSite

HarborSite

Research-stage platform for inserting therapeutic genes into safe genomic sites with engineered recombinases

harborsite.com

Отрасль
Biotech
Где находится
United States

Подтверждённая выручка: пока не подключена

HarborSite — ваш стартап? Запросите эту страницу и подключите Stripe, App Store или Google Play: ваш MRR и рост появятся здесь прямо из источника.

Запросить, если он ваш

О стартапе

HarborSite is a Harvard/Wyss Institute spinoff developing engineered recombinase enzymes to insert full-length therapeutic genes into safe sites in the genome, aiming at one-time treatments for genetic and age-related diseases. It is at research stage, with an initial focus on liver and blood cells. It is based in Boston, US, and is backed by Armenia-based SmartGate VC.

Команда

  • Erik Aznauryan, Co-founder and CEO (Основатель)
  • George Church, Co-founder and Scientific Advisory Board Chair (Основатель)
  • Tina Lebar, Co-founder and Scientific Advisory Board Member (Основатель)

Аудитория

Подписчики в соцсетях

Данные профиля: Stanbase.